GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Celltrion 068270.KS · KRW

Health Care · Biotechnology · KRX · 🇰🇷 South Korea

Compare

210,000

-0.47%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩4.16trn

FY2016FY2025

Net income

₩1.03trn

FY2016FY2025

Free cash flow

₩314.32bn

FY2016FY2025

Shareholders' equity

₩17.21trn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩4.16trn₩3.56trn₩2.18trn₩2.28trn₩1.91trn₩1.85trn₩1.13trn₩982.07bn₩949.08bn₩670.58bn
Research and development₩210.70bn₩199.72bn₩161.11bn₩139.71bn₩125.77bn₩171.44bn₩113.57bn₩108.06bn₩79.66bn₩65.36bn
Operating income₩1.16trn₩618.16bn₩651.48bn₩647.20bn₩756.86bn₩718.58bn₩381.53bn₩323.13bn₩499.59bn₩249.69bn
Net income₩1.03trn₩422.69bn₩535.65bn₩537.84bn₩579.46bn₩517.76bn₩301.03bn₩245.76bn₩368.22bn₩177.99bn
Diluted earnings per share7,217.442,963.013,754.813,888.374,242.433,794.762,209.641,802.802,707.411,309.36

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩22.33trn₩21.06trn₩19.92trn₩5.89trn₩5.67trn₩5.02trn₩3.86trn₩3.50trn₩3.29trn₩3.02trn
Cash and short-term investments———₩594.46bn₩1.22trn₩698.33bn₩627.82bn₩532.18bn₩557.92bn₩274.17bn
Total liabilities₩4.98trn₩3.48trn₩2.79trn₩1.62trn₩1.62trn₩1.59trn₩986.73bn₩907.85bn₩883.60bn₩822.97bn
Debt—₩2.19trn₩1.89trn₩792.33bn₩744.36bn₩774.40bn₩495.37bn₩516.56bn₩640.92bn₩678.94bn
Shareholders' equity₩17.21trn₩17.44trn₩16.98trn₩4.14trn₩3.92trn₩3.31trn₩2.76trn₩2.49trn₩2.29trn₩2.05trn
Shares outstanding143m143m143m138m137m136m136m136m136m136m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩646.05bn₩901.87bn₩537.16bn₩863.5m₩911.16bn₩350.75bn₩473.99bn₩364.79bn₩485.98bn₩250.89bn
Capital spending−₩331.73bn−₩333.52bn−₩353.73bn−₩311.99bn−₩321.57bn−₩541.39bn−₩286.14bn−₩187.82bn−₩96.99bn−₩178.29bn
Free cash flow₩314.32bn₩568.35bn₩183.43bn−₩311.12bn₩589.59bn−₩190.65bn₩187.86bn₩176.97bn₩388.99bn₩72.60bn
Dividends paid−₩153.76bn−₩103.60bn−₩51.66bn−₩102.45bn−₩3.8m−₩3.8m−₩3.8m−₩3.8m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩1.39trn₩1.14trn₩1.33trn₩1.03trn₩961.46bn₩841.91bn₩1.06trn₩881.93bn
Operating income₩475.77bn₩452.73bn₩543.81bn₩391.28bn₩65.92bn——₩207.69bn
Net income₩370.20bn₩346.14bn₩528.43bn₩331.35bn₩61.17bn₩108.67bn₩236.65bn₩85.59bn
Diluted earnings per share2,595.042,426.413,704.192,322.72428.80761.731,658.87599.99
Cash from operations₩413.29bn₩238.15bn₩139.88bn₩204.58bn₩188.14bn₩113.44bn₩305.93bn₩265.31bn
Capital spending−₩155.74bn−₩102.33bn−₩108.69bn−₩80.40bn−₩79.93bn−₩62.72bn−₩95.15bn−₩75.76bn
Free cash flow₩257.55bn₩135.82bn₩31.19bn₩124.18bn₩108.22bn₩50.73bn₩210.78bn₩189.55bn
Total assets₩23.70trn₩23.16trn₩22.33trn₩21.08trn₩20.55trn₩20.96trn₩21.06trn₩20.31trn
Debt₩387.20bn₩387.20bn₩387.20bn₩37.20bn₩37.20bn₩91.30bn₩86.60bn₩49.40bn
Shareholders' equity₩17.90trn₩17.67trn₩17.21trn₩16.70trn₩16.52trn₩17.14trn₩17.44trn₩16.89trn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue22.1%17.6%21.3%
Operating income21.3%10.0%16.1%
Net income24.2%14.7%20.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin23.0%25.2%28.5%30.9%
Net margin18.8%20.7%22.7%24.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings25.160.949.137.841.181.769.399.564.563.5
Price to sales6.27.212.18.912.522.918.524.925.016.9

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2013FY2012FY2011
Paid in the year714.286654.108436.072327.054628.9516.27573.1454.855
  • 1.04-for-1 split · 9 Jun 2025
  • 1.05-for-1 split · 27 Dec 2024
  • 26-for-25 split · 28 Dec 2022
  • 51-for-50 split · 29 Dec 2021
  • 1.02-for-1 split · 29 Dec 2020
  • 21-for-20 split · 27 Dec 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.